化学抗原受体修饰的T细胞疗法在转移性瘤抵抗性前列腺癌中:有希望和潜力
Leah R Tharian1, Shiv Verma2,3, Sanjay Gupta2,3,4,5,6,7
1College of Arts and Sciences, Case Western Reserve University, Cleveland, OH 44016, USA.
Cancers
|March 13, 2024
概括
前列腺癌是男性癌症死亡的主要原因. 早期发现和先进的治疗对于改善患者的治疗结果和降低死亡率至关重要.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 公共卫生 公共卫生
背景情况:
- 前列腺癌是全球影响男性的最常见的癌症.
- 在美国,它每年造成大量与癌症有关的死亡.
- 了解前列腺癌的流行病学和影响对于公共卫生倡议至关重要.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
507
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
53.3K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524